Experimental gram-negative bacterial sepsis: reevaluation of the ability of rough mutant antisera to protect mice.
D000818:Animals; D000907:Antibodies, Bacterial / Q000008:administration & dosage*; D004755:Enterobacteriaceae / Q000235:genetics; D004756:Enterobacteriaceae Infections / Q000628:therapy*; D004926:Escherichia coli / Q000276:immunology; D004927:Escherichia coli Infections / Q000628:therapy; D005260:Female; D006736:Horses; D007116:Immunization, Passive; D007710:Klebsiella Infections / Q000628:therapy; D007711:Klebsiella pneumoniae; D008297:Male; D051379:Mice; D009154:Mutation; D011512:Proteus Infections / Q000628:therapy; D011513:Proteus mirabilis; D011817:Rabbits; D012475:Salmonella / Q000276:immunology; D012486:Salmonella typhimurium / Q000276:immunology; D018805:Sepsis / Q000628:therapy*
D000907:Antibodies, Bacterial